Ginger Tablets
Ginger Tablets, licence 80092037: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Anti-nauseant Tablets, Comprimés Anti-Nausée, Gingembre
- Licence holder
- Wampole Group L.P.
- NPN or DIN-HM
- 80092037
- Status
- Active licence
- Licence date
- 3 May 2019
- Revision date
- 26 October 2024
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 25.0:1.0 Dry plant equivalent : 500.0 milligramme | 20.0 milligramme | Not calculated |
Non-medicinal ingredients
Laque d'aluminium jaune FD&C No. 5, Hypromellose, Maltodextrine, Laque d'aluminium jaune FD&C No. 6, Cellulose microcristalline, Talc, Poly(dextrose), Dioxyde de titane, Dioxyde de silicium, Macrogol 4000, Croscarmellose de sodium, Stéarate de magnésium, Poly(alcool vinylique)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 12.0 Année(s) ; maximum: 17.0 Année(s) | minimum: 1.0 Comprimé ; maximum: 2.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
| Adultes | minimum: 18.0 Année(s) | minimum: 1.0 Comprimé ; maximum: 2.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
| Enfants | minimum: 6.0 Année(s) ; maximum: 11.0 Année(s) | minimum: 1.0 Comprimé ; maximum: 2.0 Comprimé | minimum: 1.0 Tous les jours ; maximum: 3.0 Tous les jours |
Uses authorised in Canada
Help(s) prevent nausea and vomiting associated with motion sickness, and/or seasickness. Traditionally used in Herbal Medicine as an expectorant and cough suppressant (antitussive) to help relieve bronchitis as well as coughs and colds. Traditionally used in Herbal Medicine to help relieve digestive upset/disturbances including lack of appetite, nausea, digestive spasms, indigestion, dyspepsia and flatulent colic (carminative).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Source
Official Health Canada record, licence 80092037
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.